SVCM
Saturn V Capital Management Portfolio holdings
AUM
$247M
This Quarter Return
+15.33%
1 Year Return
+2.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$280M
AUM Growth
+$280M
(+5.7%)
Cap. Flow
-$8.67M
Cap. Flow
% of AUM
-3.1%
Top 10 Holdings %
Top 10 Hldgs %
70.61%
Holding
30
New
4
Increased
13
Reduced
8
Closed
5
Top Buys
| 1 |
CG Oncology
CGON
|
$19.6M |
| 2 |
MoonLake Immunotherapeutics
MLTX
|
$15.1M |
| 3 |
Ascendis Pharma
ASND
|
$13M |
| 4 |
SLN
Silence Therapeutics
SLN
|
$8.75M |
| 5 |
Phathom Pharmaceuticals
PHAT
|
$5.09M |
Top Sells
| 1 |
argenx
ARGX
|
$22.8M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$18.9M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$9.92M |
| 4 |
Amicus Therapeutics
FOLD
|
$7.08M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$6.62M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AnaptysBio
ANAB
$569M
| – | – |
-249,609
| Closed | -$6.26M |
|
27
Enliven Therapeutics
ELVN
$1.2B
| – | – |
-152,178
| Closed | -$3.56M |
|
|
28
Amicus Therapeutics
FOLD
$2.34B
| – | – |
-713,536
| Closed | -$7.08M |
|
|
RAPP
29
Rapport Therapeutics
RAPP
$643M
| – | – |
-70,000
| Closed | -$1.63M |
|
|
MORF
30
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| – | – |
-47,660
| Closed | -$1.62M |
|